Zobrazeno 1 - 10
of 36
pro vyhledávání: '"Taskoylu, O"'
Autor:
Alihanoglu YI, Yildiz BS, Özcan EE, Kilic ID, Kuru DS, Taskoylu O, Tanriverdi H, Kaftan HA, Evrengul H
Correction to: Wien Klin Wochenschr 2015 https://doi.org/10.1007/s00508-015-0854-z The original version of this article unfortunately contained a mistake. The first names of Dr. Ismail Dogu Kilic were interchanged.
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=od______3566::61b2805f48d307d71f9ea14f5d626e9d
Coronary artery aneurysms (CAAs) are uncommon and describe a localized dilatation of a coronary artery segment more than 1.5-fold compared with adjacent normal segments. The incidence of CAAs varies from 0.3 to 5.3%. Ever since the dawn of the interv
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=dedup_wf_001::0bd6044bbeb3e7afab51e057663cc786
http://acikerisim.pau.edu.tr:8080/xmlui/handle/11499/15884
http://acikerisim.pau.edu.tr:8080/xmlui/handle/11499/15884
Autor:
Alihanoglu, Y.I., Yildiz, B.S., Özcan, E.E., Kilic, D.I., Kuru, D.S., Taskoylu, O., Tanriverdi, H., Kaftan, H.A., Evrengul, H.
Background: Metabolic syndrome (MS) refers to a group of cardiovascular risk factors associated with endothelial dysfunction and impaired coronary blood flow (CBF). Homocysteine (Hcy) is another risk factor for the development of insulin resistance a
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=od______3566::e950e5997b54e52aae92c7f8f83ab00e
http://acikerisim.pau.edu.tr:8080/xmlui/handle/11499/10007
http://acikerisim.pau.edu.tr:8080/xmlui/handle/11499/10007
Autor:
Alihanoglu, YI, Yildiz, BS, Ozcan, EE, Kilic, DI, Kuru, DS, Taskoylu, O, Tanriverdi, H, Kaftan, HA, Evrengul, H
Background Metabolic syndrome (MS) refers to a group of cardiovascular risk factors associated with endothelial dysfunction and impaired coronary blood flow (CBF). Homocysteine (Hcy) is another risk factor for the development of insulin resistance an
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=dedup_wf_001::752d4dfd9de13529722d24c701a06a9a
http://acikerisim.pau.edu.tr:8080/xmlui/handle/11499/14693
http://acikerisim.pau.edu.tr:8080/xmlui/handle/11499/14693
Autor:
Alihanoglu YI, Yildiz BS, Özcan EE, Kilic ID, Kuru DS, Taskoylu O, Tanriverdi H, Kaftan HA, Evrengul H
BACKGROUND: Metabolic syndrome (MS) refers to a group of cardiovascular risk factors associated with endothelial dysfunction and impaired coronary blood flow (CBF). Homocysteine (Hcy) is another risk factor for the development of insulin resistance a
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=od______3566::eec5f419b2161b6aad7b8cad8dbb0064
Autor:
Alihanoglu, YI, Kilic, ID, Evrengul, H, Yildiz, BS, Alur, I, Uludag, B, Kuru, O, Taskoylu, O, Kaftan, HA
Background: The aim of this study is to evaluate heart rate recovery (HRR) and association between coronary flow rate and HRR in patients with metabolic syndrome (MS) who had morphologically normal coronary angiogram. Methods: Study population includ
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=od______3566::b19d9134c7595742d48ff6f2e67c7899
http://acikerisim.pau.edu.tr:8080/xmlui/handle/11499/22060
http://acikerisim.pau.edu.tr:8080/xmlui/handle/11499/22060
Autor:
Alihanoglu YI, Kilic ID, Evrengul H, Yildiz BS, Alur I, Uludag B, Kuru O, Taskoylu O, Kaftan HA
BACKGROUND: The aim of this study is to evaluate heart rate recovery (HRR) and association between coronary flow rate and HRR in patients with metabolic syndrome (MS) who had morphologically normal coronary angiogram. METHODS: Study population includ
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=od______3566::0f58763af60ec9adcf15939dc4c1df40
Coronary artery perforation (CAP) is a rare but feared complication of percutaneous coronary intervention. With the advent of new devices and technologies, interventionalists attempt more complex lesions, including more calcified or tortuous vessels
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=od______3566::7a87310f94a6354f250ed9726382a139
Autor:
Senel, S, Cobankara, V, Taskoylu, O, Karasu, U, Karapinar, H, Erdis, E, Evrengul, H, Kaya, MG
Objectives: Patients with rheumatoid arthritis (RA) are known to be at increased cardiovascular risk. Etanercept is a tumor necrosis factor alpha (TNF-alpha) blocking agent that has been successfully used in the treatment of RA. We sought to assess t
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=dedup_wf_001::57ac773bcf94ae119ff9dfe19630edcd
http://acikerisim.pau.edu.tr:8080/xmlui/handle/11499/21134
http://acikerisim.pau.edu.tr:8080/xmlui/handle/11499/21134
Background: Cardiovascular complications are one of the most common and the most serious extraskeletal manifestations of ankylosing spondylitis (AS). Infliximab, a monoclonal antibody against tumor necrosis factor, is widely used in the treatment of
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=dedup_wf_001::28455fccfdd30c360dfa6d9f654d4b7a
http://acikerisim.pau.edu.tr:8080/xmlui/handle/11499/20300
http://acikerisim.pau.edu.tr:8080/xmlui/handle/11499/20300